Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.
Showing fund managers & funds available in United Kingdom. View fund & fund manager rankings globally
Amgen boosts Patient Capital’s case but not its share price

Amgen boosts Patient Capital’s case but not its share price

A recent run of good news for Woodford Patient Capital Trust continues with Oxford Nanopore, its third biggest holding, receiving a £50 million investment from US biotech giant Amgen.

Funds & Fund Managers

All calculations in GBP, unless stated
over :
 Average Manager Total Return : 3.4% (30 September 2017 - 30 September 2018)
Total Return
1 of 104

17.1%

2 of 104

13.6%

2 of 104

13.6%

4 of 104

11.8%

4 of 104

11.8%

6 of 104

9.9%

6 of 104

9.9%

8 of 104

9.4%

8 of 104

9.4%

10 of 104

9.0%

10 of 104

9.0%

12 of 104

8.9%

13 of 104

8.4%

14 of 104

7.0%

15 of 104

6.6%

16 of 104

5.8%

17 of 104

5.8%

17 of 104

5.8%

19 of 104

5.5%

20 of 104

5.3%

21 of 104

5.3%

22 of 104

5.2%

22 of 104

5.2%

24 of 104

5.0%

25 of 104

5.0%

25 of 104

5.0%

27 of 104

4.9%

27 of 104

4.9%

29 of 104

4.9%

30 of 104

4.7%

31 of 104

4.6%

32 of 104

4.6%

33 of 104

4.6%

33 of 104

4.6%

35 of 104

4.5%

35 of 104

4.5%

37 of 104

4.3%

38 of 104

4.3%

39 of 104

4.2%

40 of 104

4.2%

41 of 104

4.2%

41 of 104

4.2%

43 of 104

4.1%

44 of 104

4.1%

45 of 104

3.8%

46 of 104

3.6%

47 of 104

3.3%

48 of 104

3.3%

49 of 104

3.2%

50 of 104

3.2%

50 of 104

3.2%

52 of 104

3.1%

52 of 104

3.1%

54 of 104

3.0%

54 of 104

3.0%

54 of 104

3.0%

57 of 104

3.0%

57 of 104

3.0%

59 of 104

2.9%

60 of 104

2.9%

61 of 104

2.8%

61 of 104

2.8%

63 of 104

2.8%

63 of 104

2.8%

65 of 104

2.6%

66 of 104

2.3%

67 of 104

2.2%

67 of 104

2.2%

67 of 104

2.2%

70 of 104

2.2%

70 of 104

2.2%

72 of 104

2.0%

73 of 104

2.0%

74 of 104

1.9%

74 of 104

1.9%

74 of 104

1.9%

77 of 104

1.8%

77 of 104

1.8%

79 of 104

1.7%

80 of 104

1.4%

81 of 104

1.1%

82 of 104

0.9%

83 of 104

0.9%

84 of 104

0.7%

84 of 104

0.7%

86 of 104

-0.3%

86 of 104

-0.3%

88 of 104

-0.3%

88 of 104

-0.3%

90 of 104

-0.3%

91 of 104

-0.4%

91 of 104

-0.4%

93 of 104

-0.6%

94 of 104

-0.9%

95 of 104

-0.9%

96 of 104

-1.2%

97 of 104

-1.5%

98 of 104

-1.8%

98 of 104

-1.8%

100 of 104

-2.9%

101 of 104

-3.1%

102 of 104

-5.0%

103 of 104

-5.4%

104 of 104

-9.1%

Managers with less than 12 months history are below. View 1 month performance
Show more managers
Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated). Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.

Neil Woodford dumps Lloyds from flagship fund

Manager sells out of Lloyds in Woodford Equity Income fund, ending flagship fund's foray into banking stocks.

Funds get Boohoo bounce as AA dents Woodford

Shares in online fashion retailer rally after 22% jump in first-half profits, buoying a number of high conviction fund manager backers.

BP and Shell boost FTSE as oil hits four-year high

Oil stocks in demand after Brent crude hits four-year high as Opec shows no sign of budging following Donald Trump's broadside.

FTSE dips but Sky and Randgold jump on takeovers

Sky tops FTSE 100 after Comcast sees off Fox in bid for broadcaster, while Randgold Resources jumps on Barrick Gold takeover.

Sky bidders gear up for weekend auction

The protracted takeover battle for Sky is on course to be settled this weekend after a surprise intervention from the Takeover Panel.

Woodford Patient Capital gets 357% energy boost

The trust's NAV has seen a material uplift after the value of its holding in Industrial Heat was significantly upgraded.

Jeremy Lang: Ronaldo, Trump and entrenched belief systems

Core beliefs are deeply embedded and tough to shake, yet what if all you once believed true is proved wrong?

Five stocks Smith & Williamson duo shorted in the great crash

Mark Boucher & Mark Swain discuss the big shorts they had in place in 2008, which helped them significantly outperform in the year Lehmans collapsed

FTSE skirts losses as investors shrug off Trump's tariffs

Investors shrug off US president Donald Trump's unveiling of $200 billion of tariffs on Chinese imports.

Miton: four yield stocks for a booming jobs market

We share the names of four dividend payers FP Miton Income fund manager Eric Moore thinks are set to benefit from changes in the job market.

Read More